Pulse Biosciences (PLSE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pulse Biosciences, Inc. recently announced the achievement of a milestone in their innovative medical technology, with the successful remapping of the first four patients using their CellFX® nsPFA™ 360° Cardiac Catheter in a First-In-Human Feasibility Study. This development could pique the interest of investors watching for advancements in the medical device sector.
For further insights into PLSE stock, check out TipRanks’ Stock Analysis page.